Resources

Resources & News

No Results Found

Try adjusting your search to find what you’re looking for.

Cell Therapy: Simplified liquid manufacturing

Case Studies
Feb 10, 2023
Southeast Asian clinical stage Cell Therapy company focused on allogeneic cell therapies required custom aliquots of media components, including human serum, cytokines, growth factors, and other components in single use containment bags to simplify their workflow.

Research: Lab requires AOF components

Case Studies
Feb 10, 2023
Southern US-based cell therapy research lab, located at world renowned cancer research institution, investigating the use of genetically modified CAR NK cells was experiencing inconsistent cell biological activity due to IL-2.

Gene Therapy:  Scaling from lab to cGMP

Case Studies
Feb 09, 2023
US-based, pre-clinical stage Gene Therapy innovator scaling products from benchtop to pilot required a nimble liquid manufacturing partner to rapidly manufacture and adjust buffers for process optimization.

Cell Therapy: Assurance of supply when scaling

Case Studies
Feb 09, 2023
US-based clinical stage Cell Therapy company focused on allogeneic platform needed to secure supply for Yssel’s T-Cell media to confidently meet their manufacturing scale up following positive results from their clinical development process.

Research: Lab improves management of FBS

Case Studies
Jan 09, 2023
US-based research laboratory, at a leading cancer research institution, struggled with the variability typically associated with FBS lots from their suppliers, which created risk and extra work for the lab’s personnel as they worked to optimize cell proliferation.

Life Science Tools: New capabilities for C&GT market

Case Studies
Jan 09, 2023
US-based, > $12B market cap, global raw material and process liquids manufacturer needed scalable cGMP process liquid manufacturing to adequately serve the rapidly growing Cell and Gene Therapy Market.

Cell Therapy: Improved aseptic process

Case Studies
Jan 09, 2023
Southeast Asia-based clinical stage company focused on allogeneic cell therapies for oncology applications was focused on reducing workflow steps and improving their aseptic processes to reduce contamination risk across the workflow.